Lipid Metabolism Disorder, also known as dyslipidemia, is related to hyperlipoproteinemia, type iii and hypobetalipoproteinemia, familial, 1. An important gene associated with Lipid Metabolism Disorder is LIPC (Lipase C, Hepatic Type), and among its related pathways/superpathways are Metabolism and Transport of inorganic cations/anions and amino acids/oligopeptides. The drugs Pitavastatin and Valsartan have been mentioned in the context of this disorder. Affiliated tissues include liver and bone marrow, and related phenotypes are Increased free cholesterol and Increased LDL uptake